Megestrol Acetate for weight loss during chemo in advanced colorectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have colorectal cancer that has been confirmed by biopsy.
- Your cancer is locally advanced (spread to nearby lymph nodes but not to distant organs).
- You have not had chemotherapy before.
- You are in good general health (able to do most daily activities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called megestrol acetate to see if it can prevent nausea and vomiting caused by very strong chemotherapy for lung cancer. If you are starting a strong chemo treatment, this study may help you feel better.
This trial tests whether a medication called megestrol acetate can help improve appetite and prevent weight loss in patients with advanced liver cancer who are receiving combination cancer treatment. The study compares the medication to placebo (inactive pill) to see if it helps patients feel hungrier and maintain their weight during treatment.
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
This trial tests whether a medicine called megestrol acetate can help improve appetite and weight in people with advanced lung cancer who are malnourished. It's for those who haven't had chemotherapy for their advanced cancer yet.
This study tests whether a special form of megestrol acetate (a medicine used to help with weight and appetite) can improve outcomes when given alongside standard chemotherapy and radiation for people with stage III non-small cell lung cancer. It is for patients who are not overweight and who are not already using other appetite-boosting medications.
This trial tests whether a medicine called megestrol acetate (an appetite stimulant) can help patients with stomach cancer who have lost weight (cachexia). The study combines this with standard chemotherapy and immunotherapy before surgery, aiming to improve nutrition and overall outcomes.
Hear when a new Neoadjuvant Chemotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.